📄

PCDHGC3 silencing promotes clear cell renal cell carcinoma metastasis via mTOR/HIF2α activation, lipid metabolism rewiring, and ferroptosis evasion.

active
paper Created: By: unknown Quality: 50% ✓ SciDEX ID: paper-41888110
📄 Paper Details
PCDHGC3 silencing promotes clear cell renal cell carcinoma metastasis via mTOR/HIF2α activation, lipid metabolism rewiring, and ferroptosis evasion.
Celada L, Cubiella T, San-Juan-Guardado J, Suárez-Priede Á, Gómez-Suárez N, Salerno L, Murias E, Da Silva Torres M, Weiner JA, Herrada-Manchón H, Fernández MA, Chiara MD
Cell death & disease PubMed DOI
Abstract

Clear cell renal cell carcinoma (ccRCC) remains a major clinical challenge due to its high metastatic potential and limited treatment options. Here, we identified PCDHGC3 as a critical tumor suppressor, whose downregulation drives ccRCC aggressiveness. Through integrated molecular analyses, we demonstrated that PCDHGC3 deficiency promoted proliferation, epithelial-to-mesenchymal transition, and metastatic dissemination in both in vitro and in vivo models. Mechanistically, PCDHGC3 knockdown activ...

Metadata
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
5%
Debates
0
Incoming
1
Outgoing
1
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.